Refine
H-BRS Bibliography
- yes (15)
Departments, institutes and facilities
Document Type
- Article (11)
- Conference Object (4)
Year of publication
Keywords
- Biomaterialien (1)
- Biomaterials (1)
- Dental follicle (1)
- Differentiation (1)
- Differenzierung (1)
- Osteogene Linie (1)
- Osteogenic lineage (1)
- Stammzelle (1)
- Stem cell (1)
- Zahnfollikel (1)
Large bone defects require fabricated bone constructs that consist of three main components: an artificial extracellular matrix scaffold, stem cells with the potential to differentiate into osteoblasts, and bioactive substances, such as osteoinductive growth factors to direct the growth and differentiation of cells toward osteogenic lineage within the scaffold.
Stem cell lineage differentiation toward adipocytes: Determination by induction media components
(2006)
It is know that mesenchymal stem cells (MSCs) actively secretemultiple biologically-active factors during their process of differentiation which gives rise to a variey of cytotypes including bone and fatcells. It is also acknowledged that the chemokines secreted throughoutMSC differentiation may play an important role in the development and growth of tumor cells, although literature data appear somewhat indeterminate due to the contradictory evidence often found.
Mesenchymal stem cells (MSCs) are an attractive cell source for Regenerative Dentistry in particular due to their ability to differentiate towards osteoblasts, among other lineages. Tooth and jaw bone loss are frequent sequelae of traumatic and pathological conditions in both the young and the elderly and must be met by appropriate prosthetic replacements. For successful osseointegration of the dental implant a sufficient bone level is necessary. Besides the utilization of bone autografts or synthetic biomaterials, medical research is more and more focused on the utilization of MSCs. Compared to cells obtained from liposuction material, ectomesenchymal stem cells derived from the head area e.g. out of dental follicles or particulate, non-vascularized bone chips show a higher differentiation potential towards osteoblasts.
Synthesis of Substituted Hydroxyapatite for Application in Bone Tissue Engineering and Drug Delivery
(2019)
We present herein a new class of resin formulations for stereolithography, named FlexSL, with a broad bandwidth of tunable mechanical properties. The novel polyether(meth)acrylate based material class has outstanding material characteristics in combination with the advantages of being a biocompatible (meth)acrylate based processing material. FlexSL shows very promising results in several initial biocompatibility tests. This emphasizes its non-toxic behavior in a biomedical environment, caused mainly by the (meth)acrylate based core components. A short overview of mechanical and processing properties will be given in the end. The herein presented novel FlexSL materials show a significant lower cytotoxicity in contrast to commercial applied acrylic stereolithography resins. Further biocompatibility tests according to ISO 10993 protocols are planned. On the one hand, there are technical applications for this material (e.g. flaps, tubes, hoses, cables, sealing parts, connectors and other technical rubber-like applications), and on the other hand, broad fields of potential biomedical applications in which the FlexSL materials can be beneficial are obvious. Especially these could be small series production of medical products with special flexible material requirements. In addition, the usage for individual soft hearing aid shells, intra-operative planning services and tools like intra-op cutting templates and sawing guides is very attractive. The possibility to modify the FlexSL resins also for high-resolution applications makes it possible to manufacture now very flexible micro-prototypes with outstanding material characteristics and very fine structures with a minimum resolution of 20 mym and a layer thickness of minimal 5 myrn. These resin formulations are applicable and adjustable to other stereolithographic equipment available on the market.